Analysis results highlight the efficacy of cough suppression therapy (CST) for those with chronic refractory cough and voice disorders. Results of a retrospective analysis show cough suppression ...
Cell Signaling Technology, Inc. (CST) has announced an agreement with Novartis under which a pilot study was performed using CST's PhosphoScan™ technology to identify phosphorylation sites and ...
The CST study was supposed to be conducted with BeiGene Ltd (NASDAQ: BGNE), which licensed the rights to VBR in China. The company will prioritize its portfolio of next-generation core inhibitors and ...
The study took place at sites in the UK, Australia, New Zealand and the European Union. Results showed that the combination of CST-103/CST-107 was both safe and well-tolerated, and importantly, that ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--CuraSen Therapeutics, Inc., a clinical-stage company developing small molecule therapies to treat neurodegenerative disease, announced that it has begun dosing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback